Managing and supporting research on pancreatic cancer therapy resistance
Administrative Core
['FUNDING_OTHER'] · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · NIH-10926942
This study is all about helping researchers work together to understand why pancreatic cancer cells can be tough to treat, so they can find better ways to help patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR (nih funded) |
| Locations | 1 site (OKLAHOMA CITY, UNITED STATES) |
| Trial ID | NIH-10926942 on ClinicalTrials.gov |
What this research studies
This research focuses on leading and managing the Acquired Resistance to Therapy Network (ARTNet) Center for Pancreatic Cancer. It aims to coordinate various projects that investigate how pancreatic cancer cells resist treatment, utilizing advanced techniques and models. The administrative core will facilitate collaboration among researchers, provide educational opportunities, and leverage expertise to enhance the understanding of therapy resistance in pancreatic cancer. By fostering a diverse and innovative research environment, the core aims to advance the field significantly.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic cancer who are experiencing challenges with treatment resistance.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with pancreatic cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for pancreatic cancer patients by overcoming therapy resistance.
How similar studies have performed: Other research initiatives focusing on therapy resistance in cancer have shown promise, indicating that this approach could yield valuable insights.
Where this research is happening
OKLAHOMA CITY, UNITED STATES
- UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR — OKLAHOMA CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SINGH, PANKAJ KUMAR — UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
- Study coordinator: SINGH, PANKAJ KUMAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Basic Cancer Research, Cancer Biology, Cancer Center, Cancer Treatment